1832 Asset Management’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

1832 Asset Management’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-7,672	Closed	-$384K	–	786
2021 Q1	$384K	Buy	7,672 +1,775	+30%	+$94.6K	﹤0.01%	498
2020 Q4	$306K	Hold	5,897	–	–	﹤0.01%	560
2020 Q3	$255K	Hold	5,897	–	–	﹤0.01%	547
2020 Q2	$252K	Buy	+5,897	New	+$244K	﹤0.01%	522

Other funds holding XPH

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return

HCIA

Hochman Cole Investment Advisors Deerfield, Illinois $255M AUM 23.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

FCBT

First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return

CX Institutional Auburn, Indiana $3.69B AUM 15.82% 1-Year Est. Return

1832 Asset Management's XPH Position: Q2 2021 in Review

1832 Asset Management sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q2 2021, closing a stake of 7,672 shares — an estimated $384K sold.

1832 Asset Management first reported a position in XPH in Q2 2020 and held it in 4 quarters. The position peaked at $384K in Q1 2021. 79 funds tracked by Wall St. Rank hold XPH as of Q2 2021.

1832 Asset Management reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q2 2021 after selling out during the quarter.
1832 Asset Management sold 7,672 State Street SPDR S&P Pharmaceuticals ETF shares in Q2 2021, an estimated $384K.
1832 Asset Management first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q2 2020 and held it in 4 quarters.
1832 Asset Management's State Street SPDR S&P Pharmaceuticals ETF position peaked at $384K in Q1 2021.
79 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q2 2021.

Based on 1832 Asset Management's 13F filing for Q2 2021, filed 16 Aug 2021.